Our latest article on targeting lipid–protein interaction(LPI) to treat Syk-mediated AML is now published in @nchembio. We report a novel strategy of targeting LPI that can overcome the problems of MDR. Our study addresses these issues with the current targeting strategies and demonstrates the successful development of a clinically active LPI inhibitor. nature.com/articles/s41589-022... #research #drugdesign #oncology #nature #phd
| @spant_18 | |
| Orcid | 0000-0002-8222-3616 |
| Countries | 🇮🇳 🇬🇧 🇺🇸 |
